Arthur J. Gallagher stock price target lowered to $353 at Evercore ISI

Arthur J. Gallagher (AJG) recently experienced price target reductions from Evercore ISI (to $353 from $370) and Goldman Sachs (to $315 from $362), following a "mixed" quarter that included misses in Brokerage organic growth, core margins, and lower-than-expected Q3 earnings and revenue. Despite these performance challenges and trading near its 52-week low, analysts maintain Outperform/Buy ratings, citing a positive long-term outlook driven by potential upside in alternative placements, robust reinsurance renewals, and a healthy deal pipeline, projecting approximately 6% growth into 2026 for the insurance brokerage.

Analysis

Arthur J. Gallagher (AJG) has experienced recent performance challenges, with Evercore ISI and Goldman Sachs both reducing their price targets to $353 and $315, respectively, while maintaining Outperform/Buy ratings. The company reported a "mixed" quarter, missing brokerage organic growth by 0.6% and core margin expectations, alongside Q3 adjusted EPS of $2.32 against a $2.54 consensus and revenue of $3.33 billion versus an anticipated $3.44 billion. These shortfalls follow a similar Q2 earnings miss.

The underperformance was attributed partly to lower seasonal EBITDAC from the newly acquired AssuredPartners business and a 60 basis point drag on organic growth from lower large life sales and international contingents. Despite these headwinds, AJG remains profitable with a P/E ratio of 38.99 and 11.2% revenue growth over the last twelve months. The stock is currently trading at $262.03, near its 52-week low of $261.04, with InvestingPro data suggesting an oversold RSI.

Analysts, however, express encouragement regarding AJG's long-term outlook, projecting approximately 6% growth into 2026, supported by 5-7% property rate per customer growth. Evercore specifically highlighted potential upside in the Alternative Placement segment, healthy reinsurance renewals, and a "decent deal pipeline" as key drivers that underpin the maintained positive ratings despite near-term estimate adjustments.

Key Decisions for Investors

• Investors should closely monitor AJG's upcoming earnings reports for signs of improved organic growth and margin performance, particularly from the integration of AssuredPartners and the Alternative Placement segment.
• Given the stock's current valuation near its 52-week low and an oversold RSI, long-term investors might consider current levels as a potential entry point, contingent on a thorough assessment of the company's ability to execute on its projected 2026 growth drivers.
• It is prudent to evaluate the sustained impact of headwinds from large life sales and international contingents on future organic growth, while also assessing the strength of the deal pipeline and reinsurance renewal trends.